Amgen 🧪🔬🧬

@Amgen · Thousand Oaks, CA, USA · joined 02 Apr 2009

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases. 🔗 Guidelines: https://t.co/IROHJVvFrV

118 712Followers

964Following

14 170Posts total

20.6KViews on collected posts

โพสต์ล่าสุด

Amgen 🧪🔬🧬@Amgen14 Sep

SCLC #NEWS: The @FDA approved a label update to the administration information for Amgen’s DLL3-targeting T-cell engager for certain patients with extensive-stage small cell lung cancer (ES-SCLC). 🔗Learn more: https://t.co/674pM0kiQ0 $AMGN https://t.co/7kAeSD8mwP

2.4K views · 16 likes · 11 reposts · 0 replies Open on X →

Amgen 🧪🔬🧬@Amgen12 Sep

💡What does progress in small cell lung cancer (SCLC) look like? At #WCLC26, we’re excited to share our latest research including data from across several studies in small cell lung cancer. Learn more: https://t.co/ZL6yTzaKGR https://t.co/d0p0cuqVSB

0:27

2K views · 9 likes · 2 reposts · 3 replies Open on X →

Amgen 🧪🔬🧬@Amgen11 Sep

On the 25th anniversary of September 11, we remember Dora Menchaca—an Amgen scientist, mentor, mother, wife, and daughter who was aboard Flight 77—along with all the lives lost that day. 🔗https://t.co/Xnhq69eCfz https://t.co/CRePUfJ71i

1.5K views · 16 likes · 3 reposts · 0 replies Open on X →

Amgen 🧪🔬🧬@Amgen8 Sep

📢 #SCLC news: Amgen announced that a Phase 3 study evaluating its DLL3-targeting therapy as part of first-line maintenance treatment for patients with extensive-stage small cell lung cancer met its primary endpoint ➡️ Learn more: https://t.co/yPD36xYGVq $AMGN https://t.co/2DkTK

0:13

12.7K views · 35 likes · 16 reposts · 0 replies Open on X →

Amgen 🧪🔬🧬@Amgen7 Sep

At Amgen, sustainability is built into how we work. From reducing energy and water use to improving the efficiency of making medicines, environmental sustainability is embedded into our operations. Learn more: https://t.co/OYyku8DXgc https://t.co/yw690AaPS3

1.9K views · 14 likes · 3 reposts · 1 replies Open on X →

เทียบกับบัญชีขนาดเดียวกัน

5 โพสต์จาก 90 วันที่ผ่านมา เทียบกับช่วง 100K–1M ผู้ติดตาม อยู่ที่ค่ามัธยฐานของช่วงผู้ติดตามพอดี.

ยอดดูมัธยฐาน1 985บัญชีนี้5 796ค่ามัธยฐานของ 100K–1M

การเข้าถึง, %1.67%บัญชีนี้1.53%ค่ามัธยฐานของ 100K–1M

การมีส่วนร่วม, %0.94%บัญชีนี้0.98%ค่ามัธยฐานของ 100K–1M

ตัวชี้วัด	บัญชีนี้	ค่ามัธยฐานของ 100K–1M	อัตราส่วน
ยอดดูมัธยฐานต่อโพสต์	1 985	5 796	0.34×
การเข้าถึง (ยอดดู ÷ ผู้ติดตาม)	1.67%	1.53%	1.09×
อัตราการมีส่วนร่วม	0.94%	0.98%	0.96×

บัญชีอื่นในช่วงนี้ → เปรียบเทียบกับบัญชีอื่น → ค่าอ้างอิงเหล่านี้คำนวณอย่างไร →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

1.9K7 Sep

12.7K8 Sep

1.5K11 Sep

2K12 Sep

2.4K14 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.94%7 Sep

0.46%8 Sep

1.25%11 Sep

0.71%12 Sep

1.11%14 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 0.98%.

What the audience does

Likes64.3%90 in total

Reposts25.0%35 in total

Replies2.9%4 in total

Quotes5.7%8 in total

Bookmarks2.1%3 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.